Disclosures

Olga Ciccarelli, MD, PhD, FRCP

Scientific Advisory Boards
Commercial: data safety monitoring for Remibrutinib (Novartis)

Funding for travel or speaker honoraria
Commercial: Speaker Honoraria: Biogen, Merck

Editorial Boards
Dr. Ciccarelli is Deputy Editor of Neurology and she serves on the Editorial Board of Multiple Sclerosis Journal.

Consultancies
Commercial: Speaker honoraria from Merck for a teaching course on diagnostic criteria in MS on September 29, 2021, and from New York Academy of Sciences/Biogen for a talk on spinal cord imaging biomarkers on October 4, 2021.

Research Support, Government Entities
Dr. Ciccarelli is NIHR Research Professor (RP-2017-08-ST2-004). Dr. Ciccarelli also receives funding from MRC (Research Grant MR/S026088/1).

Research Support, Academic Entities
Dr. Ciccarelli receives research support from the NIHR UCLH/UCL Biomedical Research Centre, NIHR, MS Society of Great Britain and Northern Ireland, National MS Society, Rosetrees Trust.

Research Support, Foundations and Societies
MS Society or Great Britain and Northern Ireland.